Literature DB >> 3022190

4-Aminopyridine-mediated increase in long-term potentiation in CA1 of the rat hippocampus.

W L Lee, R Anwyl, M Rowan.   

Abstract

The effect of 4-aminopyridine (4-AP) on long-term potentiation (LTP) was studied in the hippocampal slice preparation of the rat. Field excitatory postsynaptic potentials (EPSPs) were recorded and evoked in the stratum radiatum of the CA1. Both the low frequency EPSP and LTP of the EPSP were significantly increased by treatment with 4-AP. These effects were inhibited by increasing the magnesium concentration from 1 to 4 mM. Pretreatment with 20 microM DL-2-amino-5-phosphonovalerate antagonized only the increase in LTP produced by 4-AP. It is suggested that 4-AP enhances Ca influx either pre- or postsynaptically and thereby increases LTP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022190     DOI: 10.1016/0304-3940(86)90446-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  The effects of chronic treatment with the dihydropyridine, Bay K 8644, on hyperexcitability due to ethanol withdrawal, in vivo and in vitro.

Authors:  M A Whittington; A R Butterworth; S J Dolin; T L Patch; H J Little
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 2.  Molecular mechanisms of neuronal plasticity during learning: the role of secondary messengers.

Authors:  B I Kotlyar; A S Pivovarov
Journal:  Neurosci Behav Physiol       Date:  1990 Mar-Apr

3.  Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal.

Authors:  M A Whittington; H J Little
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

4.  A calcium channel antagonist stereoselectively decreases ethanol withdrawal hyperexcitability but not that due to bicuculline, in hippocampal slices.

Authors:  M A Whittington; H J Little
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.